Davenport & Co’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-174,589
Closed -$14.5M 1066
2023
Q2
$14.5M Buy
174,589
+49
+0% +$4.08K 0.11% 148
2023
Q1
$13.3M Buy
+174,540
New +$13.3M 0.1% 153
2022
Q4
Sell
-8,797
Closed -$698K 1027
2022
Q3
$698K Sell
8,797
-92
-1% -$7.3K 0.01% 572
2022
Q2
$660K Buy
8,889
+548
+7% +$40.7K 0.01% 591
2022
Q1
$750K Hold
8,341
0.01% 607
2021
Q4
$934K Buy
+8,341
New +$934K 0.01% 569
2018
Q4
Sell
-15,444
Closed -$1.48M 686
2018
Q3
$1.48M Buy
15,444
+3,393
+28% +$325K 0.02% 272
2018
Q2
$1.15M Sell
12,051
-4,787
-28% -$456K 0.01% 297
2018
Q1
$1.48M Buy
16,838
+3,609
+27% +$317K 0.02% 268
2017
Q4
$1.12M Sell
13,229
-455
-3% -$38.6K 0.01% 292
2017
Q3
$1.18M Buy
13,684
+3,391
+33% +$294K 0.02% 282
2017
Q2
$794K Buy
10,293
+6,118
+147% +$472K 0.01% 331
2017
Q1
$247K Sell
4,175
-200
-5% -$11.8K ﹤0.01% 532
2016
Q4
$258K Sell
4,375
-700
-14% -$41.3K ﹤0.01% 528
2016
Q3
$336K Buy
5,075
+260
+5% +$17.2K 0.01% 461
2016
Q2
$260K Buy
+4,815
New +$260K ﹤0.01% 494
2016
Q1
Sell
-3,265
Closed -$229K 614
2015
Q4
$229K Sell
3,265
-14,936
-82% -$1.05M ﹤0.01% 506
2015
Q3
$1.13M Buy
18,201
+384
+2% +$23.9K 0.02% 255
2015
Q2
$1.5M Buy
17,817
+6,156
+53% +$518K 0.02% 239
2015
Q1
$876K Buy
+11,661
New +$876K 0.01% 317
2014
Q2
Sell
-12,459
Closed -$592K 609
2014
Q1
$592K Hold
12,459
0.01% 345
2013
Q4
$541K Sell
12,459
-75
-0.6% -$3.26K 0.01% 352
2013
Q3
$540K Sell
12,534
-2,790
-18% -$120K 0.01% 340
2013
Q2
$533K Buy
+15,324
New +$533K 0.01% 306